Floatz logo

Ruxolitinib Phosphate

Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

City of Hope Medical CenterPhase 2Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
89/ 100

Competitive context

35 Active assets in the Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
City of Hope Medical Center
Phase 2BB
ETOPOSIDE
Alliance for Clinical Trials in Oncology
Phase 4BB
DEXAMETHASONE
Zhengzhou University
Phase 4BB
FILGRASTIM
City of Hope Medical Center
Phase 2BB
Inno-206
City of Hope Medical Center
Phase 2BB

View all 50 →

Same molecule, other indications

Ruxolitinib Phosphate is also rated in:

myelodysplastic/myeloproliferative neoplasmDormant
B
Indicative ·
59 / 100
View asset →
acute myeloid leukemiaDormant
B
Indicative ·
56 / 100
View asset →
myelodysplastic syndromeDormant
CCC
Indicative ·
55 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →